Illinois General Assembly - Full Text of HB5233
Illinois General Assembly

Previous General Assemblies

Full Text of HB5233  97th General Assembly




HB5233 EnrolledLRB097 20167 RPM 65645 b

1    AN ACT concerning public health.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 5. The Illinois Food, Drug and Cosmetic Act is
5amended by changing Sections 2.4, 3.22, 5, and 6 as follows:
6    (410 ILCS 620/2.4)  (from Ch. 56 1/2, par. 502.4)
7    Sec. 2.4. (a) "Drug" means (1) articles recognized in the
8official United States Pharmacopoeia - National Formulary,
9official Homeopathic Pharmacopoeia of the United States,
10United States Dispensatory, or Remington's Practice of
11Pharmacy, or any supplement to any of them; and (2) articles
12intended for use in the diagnosis, cure, mitigation, treatment
13or prevention of disease in man or other animals; and (3)
14articles (other than food) intended to affect the structure or
15any function of the body of man or other animals; and (4)
16articles intended for use as a component of any article
17specified in clause (1), (2) or (3); but does not include
18devices or their components, parts or accessories.
19    (b) "Synthetic drug product" means any product that
20contains a substance defined as a controlled substance under
21subsections (d) and (e) of Section 204 of the Illinois
22Controlled Substances Act. Products approved by the U.S. Food
23and Drug Administration for human consumption are not synthetic



HB5233 Enrolled- 2 -LRB097 20167 RPM 65645 b

1drug products.
2(Source: P.A. 84-891.)
3    (410 ILCS 620/3.22)  (from Ch. 56 1/2, par. 503.22)
4    Sec. 3.22. (a) Whoever knowingly distributes, or possesses
5with intent to distribute, human growth hormone for any use in
6humans other than the treatment of a disease or other
7recognized medical condition, where the use has been authorized
8by the Secretary of Health and Human Services and under the
9order of a physician, is guilty of a Class 3 felony, and may be
10fined an amount not to exceed $50,000. As used in this Section,
11the term "human growth hormone" means somatrem, somatropin, or
12an analogue of either of them.
13    (b) Whoever distributes, or possesses with intent to
14distribute, a synthetic drug product or a drug that is
15misbranded under this Act is guilty of a Class 2 felony and may
16be fined an amount not to exceed $100,000. A person convicted
17of a second or subsequent violation of this Section is guilty
18of a Class 1 felony, the fine for which shall not exceed
20    (c) Whoever falsely advertises a synthetic drug product is
21guilty of a Class 3 felony and may be fined an amount not to
22exceed $100,000.
23    (d) Whoever commits any offense set forth in this Section
24and the offense involves an individual under 18 years of age is
25punishable by not more than 10 years imprisonment, and twice



HB5233 Enrolled- 3 -LRB097 20167 RPM 65645 b

1the fine authorized above. Any conviction for a violation of
2this Section shall be considered a violation of the Illinois
3Controlled Substances Act for the purposes of forfeiture under
4Section 505 of such Act. As used in this Section the term
5"human growth hormone" means somatrem, somatropin, or an
6analogue of either of them. The Department of State Police and
7Department of Professional Regulation are authorized to
8investigate offenses punishable by this Section.
9    (e) Any person convicted under this Section is subject to
10the forfeiture provisions set forth in subsections (c), (d),
11(e), (f), (g), (h), and (i) of Section 3.23 of this Act.
12(Source: P.A. 87-754.)
13    (410 ILCS 620/5)  (from Ch. 56 1/2, par. 505)
14    Sec. 5. (a) A person who violates any of the provisions of
15this Act, other than Sections 3.22 and 6, is guilty of a Class
16C misdemeanor; but if the violation is committed after a
17conviction of such person under this Section has become final,
18the person shall be guilty of a Class A misdemeanor. A person
19who violates the provisions of Section 6 of this Act is guilty
20of a Class A misdemeanor; but if the violation is committed
21after a conviction of such person under this Section has become
22final, the person shall be guilty of a Class 4 felony.
23    (b) No person is subject to the penalties of subsection (a)
24of this Section for (1) violating Section 3.1 or 3.3 if he
25establishes a guaranty or undertaking signed by and containing



HB5233 Enrolled- 4 -LRB097 20167 RPM 65645 b

1the name and address of the person residing in the State of
2Illinois from whom he received the article in good faith, to
3the effect that the article is not adulterated or misbranded
4within the meaning of this Act, designating this Act; or (2)
5for having violated clause (2) of Section 3.16 if such person
6acted in good faith and had no reason to believe that the use
7of the punch, die, plate, stone or other thing involved would
8result in a drug being a counterfeit drug, or for having
9violated clause (3) of Section 3.16 if the person doing the act
10or causing it to be done acted in good faith and had no reason
11to believe that the drug was a counterfeit drug.
12    (c) No publisher, radio-broadcast licensee, agency or
13medium for the dissemination of an advertisement, except the
14manufacturer, packer, distributor or seller of the article to
15which a false advertisement relates is liable under this
16Section for the dissemination of such false advertisement
17unless he has refused on the request of the Director to furnish
18the Director the name and post office address of the
19manufacturer, packer, distributor, seller or advertising
20agency residing in the State of Illinois who causes him to
21disseminate such advertisement.
22    (d) No person shall be subject to the penalties of
23subsection (a) of this Section for a violation of Section 3
24involving misbranded food if the violation exists solely
25because the food is misbranded under subsection (c) of Section
2611 because of its advertising, and no person shall be subject



HB5233 Enrolled- 5 -LRB097 20167 RPM 65645 b

1to the penalties of subsection (a) of this Section for such a
2violation unless the violation is committed with the intent to
3defraud or mislead.
4(Source: P.A. 86-704; 87-754.)
5    (410 ILCS 620/6)  (from Ch. 56 1/2, par. 506)
6    Sec. 6. (a) When an authorized agent of the Director finds
7or has probable cause to believe that any food, drug, device or
8cosmetic is adulterated or so misbranded as to be dangerous or
9fraudulent within the meaning of this Act, or is in violation
10of Section 12, 17 or 17.1 of this Act, or is suspected to be a
11synthetic drug product, he or she shall affix to such article a
12tag or other appropriate marking giving notice that the article
13is or is suspected of being adulterated or misbranded and has
14been detained or embargoed and warning all persons not to
15remove or dispose of such article by sale or otherwise until
16permission for removal or disposal is given by such agent or
17the court. It is unlawful for any person to remove or dispose
18of such detained or embargoed article by sale or otherwise
19without such permission.
20    (b) When an article detained or embargoed under subsection
21(a) of this Section is found by such agent to be adulterated or
22misbranded or to be in violation of Section 12, 17 or 17.1 of
23this Act or is suspected to be a synthetic drug product, he or
24she shall petition the circuit court in whose jurisdiction the
25article is detained or embargoed for a libel for condemnation



HB5233 Enrolled- 6 -LRB097 20167 RPM 65645 b

1of such article. When such agent finds that an article so
2detained or embargoed is not adulterated or misbranded or is
3not a synthetic drug product, he or she shall remove the tag or
4other marking.
5    (c) If the court finds that a detained or embargoed article
6is adulterated or misbranded, such article shall, after entry
7of the judgment, be destroyed at the expense of the claimant
8thereof, under the supervision of such agent, and all court
9costs and fees, and storage and other proper expenses, shall be
10taxed against the claimant of such article or his or her agent.
11However, when the adulteration or misbranding can be corrected
12by proper labeling or processing of the article, the court,
13after entry of the judgment and after such costs, fees and
14expenses have been paid and a good and sufficient bond,
15conditioned that such article shall be so labeled or processed,
16has been executed, may by order direct that such article be
17delivered to the claimant thereof for such labeling or
18processing under the supervision of an agent of the Director.
19The expense of such supervision shall be paid by the claimant.
20The article shall be returned to the claimant and the bond
21shall be discharged on the representation to the court by the
22Director that the article is no longer in violation of this
23Act, and that the expenses of such supervision have been paid.
24    (d) Whenever the Director or any of his or her authorized
25agents finds in any room, building, vehicle of transportation
26or other structure, any meat, sea food, poultry, vegetable,



HB5233 Enrolled- 7 -LRB097 20167 RPM 65645 b

1fruit or other perishable articles which contain any filthy,
2decomposed or putrid substance, or that may be poisonous or
3deleterious to health or otherwise unsafe, the same being
4hereby declared to be a nuisance, the Director or his or her
5authorized agent shall condemn or destroy the same, or in any
6other manner render the same unusable as human food.
7(Source: P.A. 85-564.)
8    Section 10. The Illinois Controlled Substances Act is
9amended by changing Section 204 as follows:
10    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
11    Sec. 204. (a) The controlled substances listed in this
12Section are included in Schedule I.
13    (b) Unless specifically excepted or unless listed in
14another schedule, any of the following opiates, including their
15isomers, esters, ethers, salts, and salts of isomers, esters,
16and ethers, whenever the existence of such isomers, esters,
17ethers and salts is possible within the specific chemical
19        (1) Acetylmethadol;
20        (1.1) Acetyl-alpha-methylfentanyl
21    (N-[1-(1-methyl-2-phenethyl)-
22    4-piperidinyl]-N-phenylacetamide);
23        (2) Allylprodine;
24        (3) Alphacetylmethadol, except



HB5233 Enrolled- 8 -LRB097 20167 RPM 65645 b

1    levo-alphacetylmethadol (also known as levo-alpha-
2    acetylmethadol, levomethadyl acetate, or LAAM);
3        (4) Alphameprodine;
4        (5) Alphamethadol;
5        (6) Alpha-methylfentanyl
6    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
7    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
8    propanilido) piperidine;
9        (6.1) Alpha-methylthiofentanyl
10    (N-[1-methyl-2-(2-thienyl)ethyl-
11    4-piperidinyl]-N-phenylpropanamide);
12        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
13        (7.1) PEPAP
14    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
15        (8) Benzethidine;
16        (9) Betacetylmethadol;
17        (9.1) Beta-hydroxyfentanyl
18    (N-[1-(2-hydroxy-2-phenethyl)-
19    4-piperidinyl]-N-phenylpropanamide);
20        (10) Betameprodine;
21        (11) Betamethadol;
22        (12) Betaprodine;
23        (13) Clonitazene;
24        (14) Dextromoramide;
25        (15) Diampromide;
26        (16) Diethylthiambutene;



HB5233 Enrolled- 9 -LRB097 20167 RPM 65645 b

1        (17) Difenoxin;
2        (18) Dimenoxadol;
3        (19) Dimepheptanol;
4        (20) Dimethylthiambutene;
5        (21) Dioxaphetylbutyrate;
6        (22) Dipipanone;
7        (23) Ethylmethylthiambutene;
8        (24) Etonitazene;
9        (25) Etoxeridine;
10        (26) Furethidine;
11        (27) Hydroxpethidine;
12        (28) Ketobemidone;
13        (29) Levomoramide;
14        (30) Levophenacylmorphan;
15        (31) 3-Methylfentanyl
16    (N-[3-methyl-1-(2-phenylethyl)-
17    4-piperidyl]-N-phenylpropanamide);
18        (31.1) 3-Methylthiofentanyl
19    (N-[(3-methyl-1-(2-thienyl)ethyl-
20    4-piperidinyl]-N-phenylpropanamide);
21        (32) Morpheridine;
22        (33) Noracymethadol;
23        (34) Norlevorphanol;
24        (35) Normethadone;
25        (36) Norpipanone;
26        (36.1) Para-fluorofentanyl



HB5233 Enrolled- 10 -LRB097 20167 RPM 65645 b

1    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
2    4-piperidinyl]propanamide);
3        (37) Phenadoxone;
4        (38) Phenampromide;
5        (39) Phenomorphan;
6        (40) Phenoperidine;
7        (41) Piritramide;
8        (42) Proheptazine;
9        (43) Properidine;
10        (44) Propiram;
11        (45) Racemoramide;
12        (45.1) Thiofentanyl
13    (N-phenyl-N-[1-(2-thienyl)ethyl-
14    4-piperidinyl]-propanamide);
15        (46) Tilidine;
16        (47) Trimeperidine;
17        (48) Beta-hydroxy-3-methylfentanyl (other name:
18    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
19    N-phenylpropanamide).
20    (c) Unless specifically excepted or unless listed in
21another schedule, any of the following opium derivatives, its
22salts, isomers and salts of isomers, whenever the existence of
23such salts, isomers and salts of isomers is possible within the
24specific chemical designation:
25        (1) Acetorphine;
26        (2) Acetyldihydrocodeine;



HB5233 Enrolled- 11 -LRB097 20167 RPM 65645 b

1        (3) Benzylmorphine;
2        (4) Codeine methylbromide;
3        (5) Codeine-N-Oxide;
4        (6) Cyprenorphine;
5        (7) Desomorphine;
6        (8) Diacetyldihydromorphine (Dihydroheroin);
7        (9) Dihydromorphine;
8        (10) Drotebanol;
9        (11) Etorphine (except hydrochloride salt);
10        (12) Heroin;
11        (13) Hydromorphinol;
12        (14) Methyldesorphine;
13        (15) Methyldihydromorphine;
14        (16) Morphine methylbromide;
15        (17) Morphine methylsulfonate;
16        (18) Morphine-N-Oxide;
17        (19) Myrophine;
18        (20) Nicocodeine;
19        (21) Nicomorphine;
20        (22) Normorphine;
21        (23) Pholcodine;
22        (24) Thebacon.
23    (d) Unless specifically excepted or unless listed in
24another schedule, any material, compound, mixture, or
25preparation which contains any quantity of the following
26hallucinogenic substances, or which contains any of its salts,



HB5233 Enrolled- 12 -LRB097 20167 RPM 65645 b

1isomers and salts of isomers, whenever the existence of such
2salts, isomers, and salts of isomers is possible within the
3specific chemical designation (for the purposes of this
4paragraph only, the term "isomer" includes the optical,
5position and geometric isomers):
6        (1) 3,4-methylenedioxyamphetamine
7    (alpha-methyl,3,4-methylenedioxyphenethylamine,
8    methylenedioxyamphetamine, MDA);
9        (1.1) Alpha-ethyltryptamine
10    (some trade or other names: etryptamine;
11    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
12    3-(2-aminobutyl)indole; a-ET; and AET);
13        (2) 3,4-methylenedioxymethamphetamine (MDMA);
14        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
15    (also known as: N-ethyl-alpha-methyl-
16    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
17    and MDEA);
18        (2.2) N-Benzylpiperazine (BZP);
19        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
20        (4) 3,4,5-trimethoxyamphetamine (TMA);
21        (5) (Blank);
22        (6) Diethyltryptamine (DET);
23        (7) Dimethyltryptamine (DMT);
24        (7.1) 5-Methoxy-diallyltryptamine;
25        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
26        (9) Ibogaine  (some trade and other names:



HB5233 Enrolled- 13 -LRB097 20167 RPM 65645 b

1    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
2    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
3    indole; Tabernanthe iboga);
4        (10) Lysergic acid diethylamide;
5        (10.1) Salvinorin A;
6        (10.5) Salvia divinorum (meaning all parts of the plant
7    presently classified botanically as Salvia divinorum,
8    whether growing or not, the seeds thereof, any extract from
9    any part of that plant, and every compound, manufacture,
10    salts, isomers, and salts of isomers whenever the existence
11    of such salts, isomers, and salts of isomers is possible
12    within the specific chemical designation, derivative,
13    mixture, or preparation of that plant, its seeds or
14    extracts);
15        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
16        (12) Peyote (meaning all parts of the plant presently
17    classified botanically as Lophophora williamsii Lemaire,
18    whether growing or not, the seeds thereof, any extract from
19    any part of that plant, and every compound, manufacture,
20    salts, derivative, mixture, or preparation of that plant,
21    its seeds or extracts);
22        (13) N-ethyl-3-piperidyl benzilate (JB 318);
23        (14) N-methyl-3-piperidyl benzilate;
24        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
25    (also known as N-hydroxy-alpha-methyl-
26    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);



HB5233 Enrolled- 14 -LRB097 20167 RPM 65645 b

1        (15) Parahexyl; some trade or other names:
2    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
3    dibenzo (b,d) pyran; Synhexyl;
4        (16) Psilocybin;
5        (17) Psilocyn;
6        (18) Alpha-methyltryptamine (AMT);
7        (19) 2,5-dimethoxyamphetamine
8    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
9        (20) 4-bromo-2,5-dimethoxyamphetamine
10    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
11    4-bromo-2,5-DMA);
12        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
13    Some trade or other names: 2-(4-bromo-
14    2,5-dimethoxyphenyl)-1-aminoethane;
15    alpha-desmethyl DOB, 2CB, Nexus;
16        (21) 4-methoxyamphetamine
17    (4-methoxy-alpha-methylphenethylamine;
18    paramethoxyamphetamine; PMA);
19        (22) (Blank);
20        (23) Ethylamine analog of phencyclidine.
21    Some trade or other names:
22    N-ethyl-1-phenylcyclohexylamine,
23    (1-phenylcyclohexyl) ethylamine,
24    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
25        (24) Pyrrolidine analog of phencyclidine. Some trade
26    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,



HB5233 Enrolled- 15 -LRB097 20167 RPM 65645 b

1    PHP;
2        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
3        (26) 2,5-dimethoxy-4-ethylamphetamine
4    (another name: DOET);
5        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
6    (another name: TCPy);
7        (28) (Blank);
8        (29) Thiophene analog of phencyclidine (some trade
9    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
10    2-thienyl analog of phencyclidine; TPCP; TCP);
11        (30) Bufotenine (some trade or other names:
12    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
13    3-(2-dimethylaminoethyl)-5-indolol;
14    5-hydroxy-N,N-dimethyltryptamine;
15    N,N-dimethylserotonin; mappine);
16        (31)  1-Pentyl-3-(1-naphthoyl)indole 
17    Some trade or other names: JWH-018; 
18        (32) 1-Butyl-3-(1-naphthoyl)indole 
19    Some trade or other names: JWH-073;  
20        (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 
21    (2-iodophenyl)methanone 
22    Some trade or other names: AM-694;
23        (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-
24    (2-methyloctan-2-yl)phenol 
25    Some trade or other names: CP 47,497 47, 497
26    and its C6, C8 and C9 homologs;



HB5233 Enrolled- 16 -LRB097 20167 RPM 65645 b

1        (34.5) (33) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 
2    (2-methyloctan-2-yl)phenol), where side chain n=5;  
3    and homologues where side chain n=4, 6, or 7;  Some  
4    trade or other names: CP 47,497; 
5        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
6    (2-methyloctan-2-yl)-6a,7, 
7    10,10a-tetrahydrobenzo[c]chromen-1-ol
8    Some trade or other names: HU-210; 
9        (35.5) (34) (6aS,10aS)-9-(hydroxymethyl)-6,6- 
10    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
11    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
12    salts, and salts of isomers; Some trade or other  
13    names: HU-210, Dexanabinol; 
14        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
15    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
16    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
17    Some trade or other names: HU-211;
18        (37) (2-methyl-1-propyl-1H-indol-
19    3-yl)-1-naphthalenyl-methanone 
20    Some trade or other names: JWH-015;
21        (38) 4-methoxynaphthalen-1-yl-
22    (1-pentylindol-3-yl)methanone 
23    Some trade or other names: JWH-081;
24        (39) (1-Pentyl-3-(4-methyl-1-naphthoyl)indole
25    Some trade or other names: JWH-122;
26        (40) 2-(2-methylphenyl)-1-(1-pentyl-



HB5233 Enrolled- 17 -LRB097 20167 RPM 65645 b

1    1H-indol-3-yl)-ethanone 
2    Some trade or other names: JWH-251;
3        (41) 1-(2-cyclohexylethyl)-3- 
4    (2-methoxyphenylacetyl)indole 
5    Some trade or other names: RCS-8, BTW-8 and SR-18; . 
6        (42) (33) Any compound structurally derived from 
7    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
8    (1-naphthyl)methane by substitution at the 
9    nitrogen atom of the indole ring by alkyl, haloalkyl, 
10    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
11    2-(4-morpholinyl)ethyl whether or not further 
12    substituted in the indole ring to any extent, whether 
13    or not substituted in the naphthyl ring to any extent; 
14        (43) (34) Any compound structurally derived from 
15    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
16    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
17    cycloalkylmethyl, cycloalkylethyl or 
18    2-(4-morpholinyl)ethyl, whether or not further 
19    substituted in the pyrrole ring to any extent, whether 
20    or not substituted in the naphthyl ring to any extent; 
21        (44) (35) Any compound structurally derived from 
22    1-(1-naphthylmethyl)indene by substitution 
23    at the 3-position of the indene ring by alkyl, haloalkyl, 
24    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
25    2-(4-morpholinyl)ethyl whether or not further 
26    substituted in the indene ring to any extent, whether 



HB5233 Enrolled- 18 -LRB097 20167 RPM 65645 b

1    or not substituted in the naphthyl ring to any extent; 
2        (45) (36) Any compound structurally derived from 
3    3-phenylacetylindole by substitution at the 
4    nitrogen atom of the indole ring with alkyl, haloalkyl, 
5    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
6    2-(4-morpholinyl)ethyl, whether or not further 
7    substituted in the indole ring to any extent, whether 
8    or not substituted in the phenyl ring to any extent; 
9        (46) (37) Any compound structurally derived from 
10    2-(3-hydroxycyclohexyl)phenol by substitution 
11    at the 5-position of the phenolic ring by alkyl, 
12    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
13    or 2-(4-morpholinyl)ethyl, whether or not substituted 
14    in the cyclohexyl ring to any extent; . 
15        (47) (33) 3,4-Methylenedioxymethcathinone 
16    Some trade or other names: Methylone; 
17        (48) (34) 3,4-Methyenedioxypyrovalerone 
18    Some trade or other names: MDPV; 
19        (49) (35) 4-Methylmethcathinone 
20    Some trade or other names: Mephedrone; 
21        (50) (36) 4-methoxymethcathinone; 
22        (51) (37) 4-Fluoromethcathinone; 
23        (52) (38) 3-Fluoromethcathinone; . 
24        (53) (35) 2,5-Dimethoxy-4-(n)-propylthio- 
25    phenethylamine; 
26        (54) (36) 5-Methoxy-N,N-diisopropyltryptamine; . 



HB5233 Enrolled- 19 -LRB097 20167 RPM 65645 b

1        (55) Pentedrone. 
2    (e) Unless specifically excepted or unless listed in
3another schedule, any material, compound, mixture, or
4preparation which contains any quantity of the following
5substances having a depressant effect on the central nervous
6system, including its salts, isomers, and salts of isomers
7whenever the existence of such salts, isomers, and salts of
8isomers is possible within the specific chemical designation:
9        (1) mecloqualone;
10        (2) methaqualone; and
11        (3) gamma hydroxybutyric acid.
12    (f) Unless specifically excepted or unless listed in
13another schedule, any material, compound, mixture, or
14preparation which contains any quantity of the following
15substances having a stimulant effect on the central nervous
16system, including its salts, isomers, and salts of isomers:
17        (1) Fenethylline;
18        (2) N-ethylamphetamine;
19        (3) Aminorex (some other names:
20    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
21    4-5-dihydro-5-phenyl-2-oxazolamine) and its
22    salts, optical isomers, and salts of optical isomers;
23        (4) Methcathinone (some other names:
24    2-methylamino-1-phenylpropan-1-one;
25    Ephedrone; 2-(methylamino)-propiophenone;
26    alpha-(methylamino)propiophenone; N-methylcathinone;



HB5233 Enrolled- 20 -LRB097 20167 RPM 65645 b

1    methycathinone; Monomethylpropion; UR 1431) and its
2    salts, optical isomers, and salts of optical isomers;
3        (5) Cathinone (some trade or other names:
4    2-aminopropiophenone; alpha-aminopropiophenone;
5    2-amino-1-phenyl-propanone; norephedrone);
6        (6) N,N-dimethylamphetamine (also known as:
7    N,N-alpha-trimethyl-benzeneethanamine;
8    N,N-alpha-trimethylphenethylamine);
9        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
10    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
11        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
12    (g) Temporary listing of substances subject to emergency
13scheduling. Any material, compound, mixture, or preparation
14that contains any quantity of the following substances:
15        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
16    (benzylfentanyl), its optical isomers, isomers, salts,
17    and salts of isomers;
18        (2) N-[1(2-thienyl)
19   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
20   its optical isomers, salts, and salts of isomers.
21(Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11;
2297-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff.
237-22-11; 97-334, eff. 1-1-12; revised 9-14-11.)
24    Section 15. The Drug Paraphernalia Control Act is amended
25by changing Section 2 as follows:



HB5233 Enrolled- 21 -LRB097 20167 RPM 65645 b

1    (720 ILCS 600/2)  (from Ch. 56 1/2, par. 2102)
2    Sec. 2. As used in this Act, unless the context otherwise
4    (a) The term "cannabis" shall have the meaning ascribed to
5it in Section 3 of the Cannabis Control Act, as if that
6definition were incorporated herein.
7    (b) The term "controlled substance" shall have the meaning
8ascribed to it in Section 102 of the Illinois Controlled
9Substances Act, as if that definition were incorporated herein.
10    (c) "Deliver" or "delivery" means the actual, constructive
11or attempted transfer of possession, with or without
12consideration, whether or not there is an agency relationship.
13    (d) "Drug paraphernalia" means all equipment, products and
14materials of any kind, other than methamphetamine
15manufacturing materials as defined in Section 10 of the
16Methamphetamine Control and Community Protection Act, which
17are intended to be used unlawfully in planting, propagating,
18cultivating, growing, harvesting, manufacturing, compounding,
19converting, producing, processing, preparing, testing,
20analyzing, packaging, repackaging, storing, containing,
21concealing, injecting, ingesting, inhaling or otherwise
22introducing into the human body cannabis or a controlled
23substance in violation of the Cannabis Control Act, the
24Illinois Controlled Substances Act, or the Methamphetamine
25Control and Community Protection Act or a synthetic drug



HB5233 Enrolled- 22 -LRB097 20167 RPM 65645 b

1product or misbranded drug in violation of the Illinois Food,
2Drug and Cosmetic Act. It includes, but is not limited to:
3        (1) kits intended to be used unlawfully in
4    manufacturing, compounding, converting, producing,
5    processing or preparing cannabis or a controlled
6    substance;
7        (2) isomerization devices intended to be used
8    unlawfully in increasing the potency of any species of
9    plant which is cannabis or a controlled substance;
10        (3) testing equipment intended to be used unlawfully in
11    a private home for identifying or in analyzing the
12    strength, effectiveness or purity of cannabis or
13    controlled substances;
14        (4) diluents and adulterants intended to be used
15    unlawfully for cutting cannabis or a controlled substance
16    by private persons;
17        (5) objects intended to be used unlawfully in
18    ingesting, inhaling, or otherwise introducing cannabis,
19    cocaine, hashish, or hashish oil, or a synthetic drug
20    product or misbranded drug in violation of the Illinois
21    Food, Drug and Cosmetic Act into the human body including,
22    where applicable, the following items:
23            (A) water pipes;
24            (B) carburetion tubes and devices;
25            (C) smoking and carburetion masks;
26            (D) miniature cocaine spoons and cocaine vials;



HB5233 Enrolled- 23 -LRB097 20167 RPM 65645 b

1            (E) carburetor pipes;
2            (F) electric pipes;
3            (G) air-driven pipes;
4            (H) chillums;
5            (I) bongs;
6            (J) ice pipes or chillers;
7        (6) any item whose purpose, as announced or described
8    by the seller, is for use in violation of this Act.
9(Source: P.A. 93-526, eff. 8-12-03; 94-556, eff. 9-11-05.)
10    Section 99. Effective date. This Act takes effect upon
11becoming law.